Spasmolytic properties of dantrolene sodium: clinical evaluation.
D000328:Adult; D002986:Clinical Trials as Topic; D003620:Dantrolene / Q000627:therapeutic use*; D004341:Drug Evaluation; D006801:Humans; D006827:Hydantoins / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D010919:Placebos; D013035:Spasm / Q000188:drug therapy*
D006827:Hydantoins; D010919:Placebos; D003620:Dantrolene